Skip NavigationSkip to Content

Novel HOXD13 variants in syndactyly type 1b and type 1c, and a new spectrum of TP63-related disorders

  1. Author:
    Patel,Rashmi
    Singh, Subodh Kumar
    Bhattacharya, Visweswar
    Ali, Akhtar
  2. Author Address

    Banaras Hindu Univ, Inst Sci, Ctr Genet Disorders, Varanasi, Uttar Pradesh, India.GS Mem Plast Surg Hosp & Trauma Ctr, Varanasi, Uttar Pradesh, India.Banaras Hindu Univ, Inst Med Sci, Dept Plast Surg, Varanasi, Uttar Pradesh, India.NCI, NIH, Frederick, MD 21701 USA.
    1. Year: 2021
    2. Date: Jul 28
    3. Epub Date: 2021 07 28
  1. Journal: Journal of human genetics
  2. SPRINGERNATURE,
  3. Type of Article: Article
  4. ISSN: 1434-5161
  1. Abstract:

    Syndactyly is the most common limb defect depicting the bony and/or cutaneous fusion of digits. Syndactyly can be of various types depending on the digits involved in the fusion. To date, eight syndactyly-associated genes have been reported, of which HOXD13 and GJA1 have been explored in a few syndactyly but most of them have unknown underlying genetics. In the present study HOXD13, GJA1 and TP63 genes have been screened by resequencing in 24 unrelated sporadic cases with various syndactyly. The screening revealed two pathogenic HOXD13 variants, NM_000523:c.500 A > G [p.(Y167C)], and NM_000523:c.961 A > C [p.(T321P)] in syndactyly type 1b and type 1c, respectively. This is the first report to identify HOXD13 pathogenic variant in syndactyly type 1b and third report in syndactyly type 1c pathogenesis. Furthermore, this study also reports a TP63 pathogenic variant, NM_003722:c.953 G > A [p.(R318H)] in Ectrodactyly and Cleft lip and palate (ECLP). In conclusion, the current study expands the clinical spectrum of HOXD13 and TP63-related disorders.

    See More

External Sources

  1. DOI: 10.1038/s10038-021-00963-5
  2. PMID: 34321610
  3. WOS: 000678568900002

Library Notes

  1. Fiscal Year: FY2020-2021

Your Recently Viewed Publications:

HIV-1 Maturation: Lessons Learned from Inhibitors
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel